Chronic Liver Disease Foundation
CLDF 2025 20 - 22 March 2025

Real-world baseline characteristics of patients with obesity or overweight and comorbid MASH receiving semaglutide

Authors :

Husam Albarmawi1; Alia Yousif2; Abdalla Aly1; Firas Dabbous2; Samuel Huse2; Maximilian Kurt Jara1
Affiliations
View Details Hide Details
06:12
Keywords
MASH
Congress poster
GLP-1 RA
Semaglutide
RWE HEOR